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This special issue of Cardiovascular Psychiatry and Neurology
marks its ﬁrst year since we launched the open access
journal dedicated to publishing original preclinical/basic
and research on biological mechanisms of and treatments
for co-occurring cardiovascular disorders and disorders of
the central nervous system (CNS). As suggested earlier
(by the paper entitled “The heart-brain connection begets
cardiovascular psychiatry and neurology” by Hari Manev),
at least three scenarios could be at play in these disorders: (1)
the primary pathological mechanism in the cardiovascular
system triggers a nervous system dysfunction, (2) the pri-
mary pathological mechanism in the nervous system triggers
a cardiovascular pathology by disrupting the physiologi-
cal links between the two systems, and (3) the primary
pathology is in a biological mechanism that is normally
operativeinboththenervousandthecardiovascularsystems,
thus causing the cooccurrence of pathologies, that is, the
cooccurring pathologies share a pathobiological mechanism
butdonotnecessarilycauseeachother.Theongoingresearch
explores the validity of these conceptual scenarios.
Whereas the evidence for the association of cardiovascu-
lar and CNS disorders derives primarily from epidemiolog-
ical studies, direct evidence and experimental data are just
beginning to emerge to support this notion. Diﬃculties in
directly demonstrating and explaining the cooccurrence of
cardiovascular and CNS disorders lie in part in the limita-
tions of their respective animal models (in particular animal
models of psychiatric disorders) and in part in conceptual
uncertainties regarding the mechanisms linking heart-brain
pathologies that hamper respective clinical research. Histori-
cally, bold hypotheses along with serendipitous observations
have been instrumental in breakthrough discoveries.
This collection of hypotheses on mechanisms linking
cardiovascular and psychiatric/neurological disorders has
been assembled with the goal of stimulating discussions
in this ﬁeld of bioscience and medicine. The postulated
mechanisms range from molecular targets and pathways
(the papers by S´ ebastien S. H´ ebert entitled “Putative role
of microRNA regulated pathways in comorbid neurologi-
cal and cardiovascular disorders”, by David P. Gavin and
Rajiv P. Sharma entitled “Chromatin from peripheral blood
mononuclear cells as biomarkers for epigenetic abnormal-
ities in schizophrenia”, by Neil R. Smalheiser entitled “Do
neural cells communicate with endothelial cells via secretory
exosomes and microvesicles?” by Stephen D. Skaper and
Pietro Giusti entitled “P2X7 receptors as a transducer in the
cooccurrence of neurological/psychiatric and cardiovascular
disorders: A hypothesis”, by Charles D Nichols entitled
“Serotonin 5-HT2A receptor function as a contributing
factor to both neuropsychiatric and cardiovascular diseases”
by Hu Chen entitled “Possible role of platelet GluR1 recep-
tors in comorbid depression and cardiovascular disease”,
by Susana Roque, Margarida Correia Neves, Ana Raquel
Mesquita, Joana Almeida Palha, and Nuno Sousa entitled
“Interleukin-10: A key cytokine in depression?” by Jin Chu
and Domenico Pratic` o entitled “The 5-Lipoxygenase as
a common pathway for pathological brain and vascular
aging”, by Jane Pei-Chen Chang, Yi-Ting Chen, and Kuan-
Pin Su entitled “Omega-3 polyunsaturated fatty acids (n-3
PUFAs)incardiovasculardisease(CVD)anddepression:The
Missing Link?” by Janusz K. Rybakowski entitled “Matrix
metalloproteinase-9 (MMP9)—a mediating enzyme in car-
diovascular disease, cancer, and neuropsychiatric disorders”,
and by Thomas M¨ uller entitled “Possible treatment concepts
for the Levodopa related hyperhomocysteinemia”) to system
functioning (the papers by Britta A. Larsen and Nicholas J. S.
Christenfeld entitled “Cardiovascular disease and psychiatric
comorbidity: The potential role of perseverative cognition”2 Cardiovascular Psychiatry and Neurology
and by Hadar Shalev, Yonatan Serlin, and Alon Friedman
entitled “Breaching the blood-brain barrier as a gate to
psychiatric disorder”). We hope that exploring the hypothe-
ses presented in this special issue and, more generally,
focusing on the putative mechanisms of the cooccurrence
of cardiovascular and CNS disorders will help us to identify
unexpected and novel therapeutic targets and to ultimately
lead to better treatment of both types of disorders.
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